lopinavir has been researched along with Respiratory Tract Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Anderson, DE; Ang, LW; Chan, KS; Chan, M; Chen, MI; Cui, L; Kalimuddin, S; Kurupatham, L; Lau, SK; Lee, VJM; Leo, YS; Lin, RTP; Loh, J; Low, JG; Lye, DC; Mak, TM; Marimuthu, K; Ng, OT; Ng, TY; Ong, SWX; Said, Z; Tan, BH; Tan, SY; Tan, TY; Vasoo, S; Wang, LF; Young, BE | 1 |
Amedeo, A; Beci, G; Calza, L; Cipolli, M; Cucchetto, G; Giglia, M; Guardigni, V; Rosselli Del Turco, E; Verucchi, G; Viale, P | 1 |
Haagmans, BL; Koopmans, MP; Koulouris, NG; Koutsoukou, A; Osterhaus, AD; Pontikis, K; Raj, VS; Spanakis, N; Tsakris, A; Tsiodras, S | 1 |
3 other study(ies) available for lopinavir and Respiratory Tract Infections
Article | Year |
---|---|
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.
Topics: Adult; Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Female; Humans; Lopinavir; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Polymerase Chain Reaction; Respiratory Tract Infections; Ritonavir; SARS-CoV-2; Singapore; Virus Shedding | 2020 |
SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?
Topics: Adult; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cystic Fibrosis; Drug Combinations; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Oxygen Inhalation Therapy; Pneumonia, Viral; Receptors, Interleukin-6; Respiratory Function Tests; Respiratory Tract Infections; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen.
Topics: Antiviral Agents; Coronavirus Infections; Drug Combinations; Drug Therapy, Combination; Greece; Humans; Lopinavir; Male; Middle East Respiratory Syndrome Coronavirus; Phylogeny; Respiratory Tract Infections; Ribavirin; Ritonavir; Viremia; Virus Shedding | 2014 |